Skip to main content
CCAP
NASDAQ Unknown

Crescent Capital BDC Q3: NAV Falls to $17.72 From $19.10, Non-Accruals Rise to 12 Companies

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Asset Management Stocks · Financial
Sentiment info
Negative
Importance info
7
Price
$9.24
Mkt Cap
$340.457M
52W Low
$8.395
52W High
$15.175
52W Position info
10% above low
Off High info
39% below high
Rel. Volume info
0.9× avg
Market data snapshot near publication time

CCAP is trading near its 52-week low of $8.395 (10% above the low).

Summary

Crescent Capital BDC's Q3 2026 report shows NAV per share down to $17.72 from $19.10 at year-end, lower net investment income, and non-accruals up to twelve portfolio companies, partly offset by reduced management and incentive fees.


Key Events · Earnings and Guidance · CCAP

  • NAV Per Share Falls to $17.72

    Net asset value per share declined to $17.72 at September 30, 2026 from $19.10 at December 31, 2025, while total net assets fell to $652,932 thousand from $706,038 thousand.

  • Nine-Month Net Result Turns Negative

    For the nine months ended September 30, 2026, the net decrease in net assets resulting from operations was $8,646 thousand, versus a $26,019 thousand increase in the prior-year period.

  • Net Investment Income Drops

    Net investment income fell to $42,281 thousand from $50,437 thousand a year earlier, as total investment income declined to $111,121 thousand from $126,473 thousand.

  • Non-Accruals Rise to Twelve Companies

    Twelve portfolio companies were on non-accrual status at September 30, 2026, representing 4.7% of total debt investments at cost and 2.2% at fair value, up from eleven at December 31, 2025.


Analysis · CCAP · Unknown

The headline is NAV erosion: net asset value per share dropped to $17.72 from $19.10 at year-end 2025, and the nine-month net decrease in net assets from operations was $8,646 thousand versus a $26,019 thousand increase a year earlier. Net investment income fell to $42,281 thousand from $50,437 thousand as total investment income declined to $111,121 thousand from $126,473 thousand. Non-accrual names rose to twelve portfolio companies, 4.7% of debt investments at cost. The one offset is cost: the base management fee was cut to 1.00% from 1.25% and the income incentive fee to 15.0% from 17.5% effective April 1, 2026, which trims the expense drag on future earnings.

How filings like this one have moved

In the 30 days to Nov 10, 2026, 36.4% of the 3168 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, CCAP was trading at $9.24 on NASDAQ in the Unknown sector, with a market capitalization of approximately $340.5M. The 52-week trading range was $8.40 to $15.18. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

CCAP - Latest Insights

CCAP
Nov 09, 2026, 4:15 PM EST
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $9.24
Real-time Price: $9.55 info
Change: +$0.310 (+3%) info
Market Cap: $340.457M info
CCAP
Nov 09, 2026, 4:10 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $9.24
Real-time Price: $9.55 info
Change: +$0.310 (+3%) info
Market Cap: $340.457M info
CCAP
Aug 10, 2026, 4:35 PM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $11.23
Real-time Price: $9.55 info
Change: -$1.68 (-15%) info
Market Cap: $340.457M info
CCAP
Aug 10, 2026, 4:15 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $11.23
Real-time Price: $9.55 info
Change: -$1.68 (-15%) info
Market Cap: $340.457M info
CCAP
Aug 10, 2026, 4:07 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $11.23
Real-time Price: $9.55 info
Change: -$1.68 (-15%) info
Market Cap: $340.457M info